Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR.
- 346 Open Clinical Trials
- 42 New Clinical Trials
- 1,496 New Patients
- 245 Principal Investigators
- 18 New Faculty Recruits*
- 3 Newly Tenured Investigators*
- 281/70 Staff Scientists/Staff Clinicians
- ~500 Technical Lab Staff
- 697/118 Postdoctoral/Clinical Fellows
- 338/72 Postbaccalaureate/Predoctoral Students
- 162 Summer Students
- >1,100 Articles in Peer-Reviewed Journals
- 64 Technology Facilities and Platforms
Technology Transfer Activities
- 63 New Employee Invention Reports
- 42 Issued U.S. Patents
- 29 New Cooperative Research and Development Agreements (CRADAs)
- 184 Active CRADAs
- 85 Clinical CRADAs
- 7 Umbrella CRADAs
- 12 New Clinical Trial Agreements (CTAs)
- 113 Active CTAs
- 120 New Licenses for CCR Technologies
- 668 Active Licenses
The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. The TTC supports technology development activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices, software and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner.
For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit (ncitechtransfer@mail.nih.gov).
Numbers are for FY22 unless otherwise marked.
*Numbers are for calendar year 2022.